Panacea Biotec Ltd

BSE Code : 531349
NSE Symbol : PANACEABIO
ISIN : INE922B01023
Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

Trade Now

Get Quotes

429.10 -8.45(-1.93%)

Open Price (₹)

438.65

Prev. Close (₹)

437.55

Volume (No’s)

89,487

Market Cap (₹)

2,628.27

Low Price (₹)

425.45

High Price (₹)

438.85 Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Book Closure

From Date	To Date	Announcement
30-May-2025	NA	Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31 2025 and passing over of dividend on equity as well as preference shares for the said Financial Year Outcome of Board Meeting held on May 30, 2025. Passing over of dividend on the equity as well as preference shares of the Company for the financial year 2024-25, on account of losses during the year. (As Per BSE Announcement Dated on 30.05.2025)
01-Apr-2025	NA	Please find attached disclosure regarding appointment / re-appointment of Directors
31-Mar-2025	NA	We would like to inform you that Mr. Narotam Kumar Juneja non-executive non independent director of the Company was re-appointed as director liable to retire by rotation in the AGM held on 27.09.2024 for a period upto 31.03.2025. Accordingly he has completed his tenure as non-executive non-independent director and consequently ceased to be director of the Company on 31.03.2025. Similarly he has also completed his tenure as Whole-time Director in the Companys material subsidiary Panacea Biotec Pharma Ltd. on 31.03.2025. The details as required under SEBI Circular dated 13.07.2023 are attached herewith.
29-Mar-2025	31-Mar-2025	Please find attached a copy of the Postal Ballot Notice dated February 14 2025 along with Annexures thereto being sent to the shareholders through email only for the purpose of obtaining their approval on the Resolutions as mentioned in the said Notice. We would like to inform you that as per the Scrutinizer''s Report, all the resolutions mentioned in the Postal Ballot notice dated February 14, 2025 have been passed by the shareholders with requisite majority. The detailed voting results along with Scrutinizer''s Report are attached herewith. (As Per Bse Announcement Dated on 31.03.2025)
29-Mar-2025	NA	We would like to inform you that Mrs. Manjula Upadhyay Independent Director of the Company has completed her second and final term of 5 consecutive years as Independent Director on March 29 2025 and consequently she has ceased to be the director of the Company. The details required to be disclosed as per SEBI Circular dated July 13 2023 are attached herewith.